✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹40,142 Cr.
P/E
60.71
About
Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that manufactures and markets various formulations and APIs for different therapeutic segments. With a global pre… Read more
Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that ma… Read more
Low
1059
52W Range
High
1709
  • Ipca Laboratories
  • Glaxosmithkline Phar
  • Glenmark Pharma
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0.81 %
(as of Jul 22)
Anti - Diabetes - Market Share
1.03 %
(as of Jul 22)
Anti-Infectives - Market Share
55.08 %
(as of Nov 21)
Anti-Malarial - Market Share
3.84 %
(as of Nov 21)
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Blood Related - Market Share
2.09 %
(as of Jul 22)
Cardiovascular - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Branded Generics

Location Wise Break-Up - Generics

Location Wise Break-Up - API

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    • Bharat Dynamics Ltd.
    • Elgi Equipments Ltd.
    • Borosil Renewables Ltd.
    • GMM Pfaudler Ltd.
    • Gulshan Polyols Ltd.
    FAQs on Ipca Laboratories Ltd. Business

    IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.

    Ipca Laboratories major competitors are Glaxosmithkline Phar, Glenmark Pharma, Ajanta Pharma, Gland Pharma, JB Chem & Pharma, Natco Pharma, Wockhardt.
    Market Cap of Ipca Laboratories is ₹40,142 Crs.
    While the median market cap of its peers are ₹29,324 Crs.

    Ipca Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Ipca Laboratories is 7.1 and is ranked 6 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Jun Mar Dec Sep Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis